• Login
Skip to main content Skip to navigation

Search form

Select a Country

zoetis.com
zoetisUS.com
  • Argentina
  • Australia
  • Austria
  • Belgium
  • Brazil
  • Bulgaria
  • Canada
  • Chile
  • China
  • Colombia
  • Costa Rica
  • Croatia
  • Czech Republic
  • Ecuador
  • Egypt
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • India
  • Indonesia
  • Ireland
  • Israel
  • Italy
  • Japan
  • Latvia
  • Lithuania
  • Malaysia
  • Mexico
  • Morocco
  • Netherlands
  • New Zealand
  • Peru
  • Philippines
  • Poland
  • Portugal
  • Romania
  • Russia
  • Serbia
  • Slovakia
  • Slovenia
  • South Africa
  • South Korea
  • Spain
  • Switzerland
  • Taiwan
  • Thailand
  • Turkey
  • Ukraine
  • United Kingdom
  • United States
  • Venezuela
  • Vietnam

Header Menu

  • Investors
  • News & Media
  • Careers
  • Contact Us
Home

Main menu

  • About Us
    • Zoetis at a Glance  
    • Vision & Mission  
    • History  
    • Zoetis Executive Team  
    • Corporate Governance  
    • Corporate Compliance  
    • Company Locations  
      
  • Products & Services
    • Companion Animals  
    • Farm Animals  
    • Diagnostics  
    • Genetics  
      
  • Innovation
    • Research & Development  
    • Strategic Partnerships  
    • Global Manufacturing & Supply  
      
  • Animal Health
    • Growing Industry  
    • Farm Animal Health  
    • Companion Animal Health  
      
  • Responsibility
    • Advancing the Veterinary Profession  
    • Agricultural Development  
    • Making a Difference  
      
  • +-Text Size
  • Print
  • Share
    •          
  • Home
  • Investors
  • Investors
  • Shareholder Services
  • Financial Reports
  • SEC Filings
  • Stock Information
  • CEO/CFO Certifications
  • Investment News
    • Financial
    • Corporate
  • Events & Presentations
  • Sign Up for Alerts
Advanced Search

Investors

Welcome to the Zoetis Investment Center. We are committed to providing you with useful information and convenient tools so that you can make informed decisions about your investment. Use our Investment Center to learn more about our company.

Advanced Search

News

  • May 16, 2013
    FDA Approves APOQUEL® (oclacitinib tablet) to Control Itch and Inflammation in Allergic Dogs
  • April 30, 2013
    Zoetis™ Reports First-Quarter 2013 Results
  • March 28, 2013
    Zoetis™ Declares Second-Quarter 2013 Dividend
More Financial News
Financial ReportsFuture financial reports will be available here. SEC FilingsTo access recent SEC filings, click here. Shareholder ServicesZoetis has authorized Computershare Trust Company, N.A. as its transfer agent. Stock Information20 minute delayed data provided by Yahoo! Finance.
Facebook Twitter YouTube
    •          

Zoetis at a Glance

Latest News
Vision & Mission
Fact Sheet

Species

Beef Cattle
Cats
Dairy Cattle
Dogs
Fish
Horses
Pigs
Poultry
Sheep

Information for

Customers
Investors
Journalists
Strategic Partners
Suppliers
Job Seekers

Popular Links

About Us
Locations
Contact Us

Connect with Us

Facebook
Twitter
YouTube
RSS Feeds

Copyright © Zoetis 2013 All rights reserved. The product information provided in this site is intended only for residents of the United States. The products discussed herein may have different product labeling in different countries.

Select a Country

zoetis.com
zoetisUS.com
  • Argentina
  • Australia
  • Austria
  • Belgium
  • Brazil
  • Bulgaria
  • Canada
  • Chile
  • China
  • Colombia
  • Costa Rica
  • Croatia
  • Czech Republic
  • Ecuador
  • Egypt
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • India
  • Indonesia
  • Ireland
  • Israel
  • Italy
  • Japan
  • Latvia
  • Lithuania
  • Malaysia
  • Mexico
  • Morocco
  • Netherlands
  • New Zealand
  • Peru
  • Philippines
  • Poland
  • Portugal
  • Romania
  • Russia
  • Serbia
  • Slovakia
  • Slovenia
  • South Africa
  • South Korea
  • Spain
  • Switzerland
  • Taiwan
  • Thailand
  • Turkey
  • Ukraine
  • United Kingdom
  • United States
  • Venezuela
  • Vietnam

Footer Menu

  • Home
  • Privacy Policy
  • Terms of Use
Business Wire InvestorHQ℠